Detalhe da pesquisa
1.
Strategies to enhance the response of liver cancer to pharmacological treatments.
Am J Physiol Cell Physiol
; 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38708523
2.
Serum lipidome unravels a diagnostic potential in bile acid diarrhoea.
Gut
; 72(9): 1698-1708, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37072179
3.
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma.
J Hepatol
; 79(1): 93-108, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36868481
4.
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions.
Gut
; 71(8): 1669-1683, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35580963
5.
Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models.
J Hepatol
; 77(1): 177-190, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35217064
6.
Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System.
Hepatology
; 73(6): 2311-2325, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33073396
7.
Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH).
Gastroenterol Hepatol
; 45(9): 724-734, 2022 Nov.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-35248669
8.
Current and novel therapeutic opportunities for systemic therapy in biliary cancer.
Br J Cancer
; 123(7): 1047-1059, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32694694
9.
Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.
Lancet
; 393(10174): 899-909, 2019 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30773280
10.
Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy.
Hepatology
; 70(4): 1246-1261, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30972782
11.
Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis.
Hepatology
; 70(2): 547-562, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30325540
12.
Diagnostic and prognostic biomarkers in cholangiocarcinoma.
Liver Int
; 39 Suppl 1: 108-122, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30843325
13.
Role of the placenta in serum autotaxin elevation during maternal cholestasis.
Am J Physiol Gastrointest Liver Physiol
; 315(3): G399-G407, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29927323
14.
The search for novel diagnostic and prognostic biomarkers in cholangiocarcinoma.
Biochim Biophys Acta Mol Basis Dis
; 1864(4 Pt B): 1468-1477, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28782657
15.
Chemoresistance and chemosensitization in cholangiocarcinoma.
Biochim Biophys Acta Mol Basis Dis
; 1864(4 Pt B): 1444-1453, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28600147
16.
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma.
Hepatology
; 66(4): 1125-1143, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28555885
18.
Correction: Current and novel therapeutic opportunities for systemic therapy in biliary cancer.
Br J Cancer
; 125(6): 904, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34226686
19.
Effect of ursodeoxycholic acid treatment on the altered progesterone and bile acid homeostasis in the mother-placenta-foetus trio during cholestasis of pregnancy.
Br J Clin Pharmacol
; 79(2): 316-29, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25099365
20.
Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib.
Hepatology
; 58(3): 1065-73, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23532667